Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Schleich (Liege, Belgium), R. Chaudhuri (Glasgow, United Kingdom), G. Canonica (Milan, Italy), X. Munoz Gall (Barcelona, Spain), F. Funke (Essen, Germany), B. Pek (Quebec, QC, Canada), S. Pollard (Louisville, KY, United States of America), A. Maxwell (Stevenage, Hertfordshire, United Kingdom), S. Joksaite (London, United Kingdom), R. Price (Stevenage, Hertfordshire, United Kingdom), R. O'Reilly (Stevenage, Hertfordshire, United Kingdom), M. Van Dyke (Collegeville, PA, United States of America), S. Yang (Collegeville, PA, United States of America), P. Howarth (Brentford, Middlesex, United Kingdom). Mepolizumab improves lung function under real-world settings in REALITI-A study. 2260

Member's Comments

No comment yet.

Related content which might interest you: Budesonide/formoterol improves the wellbeing of patients with COPD: results from a real-life setting Source: Eur Respir J 2005; 26: Suppl. 49, 289s Year: 2005 Interpreting lung function in clinical practice Source: Annual Congress 2006 - PG5 - Respiratory physiology: interpreting lung function in health and disease Year: 2006 FEV6: a useful outcome measure of lung function in COPD as assessed in a large clinical study with roflumilast Source: Eur Respir J 2004; 24: Suppl. 48, 342s Year: 2004 Improvements in functional and cognitive status following short-term pulmonary rehabilitation in COPD lung transplant recipients: a pilot study Source: ERJ Open Res, 5 (3) 00060-2019; 10.1183/23120541.00060-2019 Year: 2019 Patients with persistent asthma may have poor disease control despite normal lung function: baseline data from a pan-European real-life study Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009 Year: 2009 Computed-tomography-based radiomics features for staging of interstitial lung disease – transferability from experimental to human lung fibrosis - a proof-of-concept study Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update Year: 2019 Preliminary data from a clinical trial: An Internet based asthma-monitoring tool increases lung function and decrease airway hyperresponsiveness Source: Eur Respir J 2003; 22: Suppl. 45, 535s Year: 2003 No clinical benefit for the use of respiratory system admittance to measure lung function in young children Source: Annual Congress 2008 - Diagnostic paediatric lung function: technical and clinical aspects Year: 2008 Pilot data of the short-term effects of e-cigarrette vaping on lung function Source: International Congress 2018 – New methods and concepts in tests of lung and respiratory muscle function Year: 2018 How can we improve our assessment of inflammation in clinical studies of COPD that use bronchial biopsies? Source: Eur Respir J 2006; 27: 248-249 Year: 2006 A comparative study to evaluate the effects of salmetrol/fluticasone and formoterol/budesonide combinations on lung functions and sleep quality in asthma Source: Annual Congress 2011 - Airways disease comorbidities and general aspects Year: 2011 COPD integrated disease management, from controlled trial to real-world primary care; a cohort study. Source: Virtual Congress 2020 – Organising respiratory disease management in primary care Year: 2020 Once-daily QVA149 provides clinically meaningful improvements in lung function and clinical outcomes Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013 Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients Source: Eur Respir J 2001; 18: 306-315 Year: 2001 Improvements in activation for self-management in patients with chronic airway disease via the COPDnet diagnostic trajectory in secondary care; a pilot study. Source: International Congress 2018 – Integrated care and non-pharmacological management of COPD Year: 2018 Does ambulatory oxygen improve quality of life in patients with fibrotic lung disease? Results from the AmbOx trial Source: Breathe, 15 (2) 140; 10.1183/20734735.0002-2019 Year: 2019 Efficacy and safety of pirfenidone in patients with IPF. A single center real-life experience. Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside Year: 2017 Early detection of lung cancer – the NELSON trial results into real-life practice Source: ERS webinars 2019 - Early detection of lung cancer – the NELSON trial results into real-life practice Year: 2019 A study to evaluate the lung function in bronchiectasis Source: Annual Congress 2008 - Beyond spirometry: the skills behind lung function testing Year: 2008 Effects of a comprehensive pulmonary rehabilitation (PR)-program on frailty in lung transplantation candidates – a prospective observational study Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation Year: 2020